Bazedoxifene acetate Catalog No.:M10044-2 TCS-JNK-6a binds competitively and reversibly

TCS-JNK-6a binds competitively and reversibly to the ATP site

2R)-2-hydroxycyclohexyl]amino}-1

92 µM toward JMJD2E

Chlorogenic acids contain no chlorine

4 Formulations containing mitoxantrone have been used in the treatment of cancer and multiple sclerosis

Bazedoxifene acetate Catalog No.:M10044-2 TCS-JNK-6a binds competitively and reversiblyBazedoxifene, also known as WAY 140424, is a third generation selective estrogen receptor modulator (SERM), developed by Pfizer following the completion of their takeover of Wyeth Pharmaceuticals. In late 2013, Pfizer received approval for bazedoxifene as part of the combination drug DUAVEE in the prevention (not treatment) of postmenopausal osteoporosis. Bazedoxifene is an indole based ER ligand that binds to both ER (IC50 = 26 nM) and ER (IC50 = 99